The chemical class known as resistin-like α inhibitors encompasses a group of small organic molecules that are designed to specifically target and modulate the activity of resistin-like α (RETNLA) proteins within biological systems. These inhibitors are meticulously synthesized with the intent of disrupting the normal binding interactions or enzymatic functions associated with resistin-like α proteins. By doing so, they aim to exert a regulatory influence on cellular pathways and physiological processes that involve these proteins. The design and development of resistin-like α inhibitors typically involve a deep understanding of the three-dimensional structure of the target protein, enabling the creation of compounds that can either competitively bind to active sites or allosterically modulate the protein's function.
The intricate chemical structures of these inhibitors are tailored to achieve high selectivity and potency, ensuring a precise and effective interference with the biological activities of resistin-like α proteins. As research in this field continues to advance, the discovery and characterization of novel resistin-like α inhibitors hold the potential to reveal new insights into the intricate mechanisms underlying various biological processes in which these proteins are involved.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
R 568 hydrochloride | 177172-49-5 | sc-361302 sc-361302A | 10 mg 50 mg | $214.00 $877.00 | 4 | |
This compound was shown to inhibit resistin-mediated insulin resistance and reduce glucose intolerance in experimental studies. | ||||||